University of Pittsburgh

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Pittsburgh sits in the top decile of US sponsors by registered trial count (#22 of 15,742 sponsors by registered trial count).

1,238 total trials 160 currently recruiting 917 completed early-phase tilt top decile by trial count

University of Pittsburgh: 1,238 sponsored US clinical trials, 160 recruiting.

University of Pittsburgh sponsors 1,238 registered US clinical trials on ClinicalTrials.gov, 160 of them currently recruiting, and 917 completed. 84 of these trials are in Phase 3-4 (later-stage) and 160 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 17 trials.

Top-decile sponsor footprint

University of Pittsburgh ranks in the top decile of sponsors by registered trial count (#22 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 66/100

917 of 1,014 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,238 total, page 18 of 25

COMPLETED NA

Continuous L2 Paravertebral Block Versus Continuous Lumbar Plexus Block for Postoperative Analgesia

NCT01571492

COMPLETED Phase 1

Healthy Bodies, Healthy Hearts: A Physical Activity Intervention Trial

NCT01099007

COMPLETED NA

The Use of Neuromuscular Electrical Stimulation to Reverse Muscle Atrophy in Patients With Rheumatoid Arthritis

NCT00924625

TERMINATED NA

Computed Tomography (CT) Perfusion Imaging of Lung Cancer

NCT00905801

COMPLETED Phase 2

Comparison Study of PTHrP and PTH to Treat Osteoporosis

NCT00853723

COMPLETED

A Validation Study for Detecting Chlamydia and Gonorrhea in Rectal Samples

NCT00827697

COMPLETED

Identification of Carotid Vasa Vasorum and Correlation With Acute Coronary Events

NCT01436773

TERMINATED

Genetic Predictors of Outcome in HCM Patients

NCT00156429

COMPLETED NA

Translating the Diabetes Prevention Program Into a Virtual Lifestyle Management Program

NCT00867425

COMPLETED NA

Brief Behavioral Treatment of Insomnia in Military Veterans: Phase 2 (BBTIMVII)

NCT00840255

COMPLETED NA

Health Promotion in Early Adolescence: Sleep, Activity, and Emotion Regulation

NCT01289197

COMPLETED

Multinational Study of Acinetobacter Bloodstream Infection: Clinical Outcomes and Global Epidemiology-PITT Protocol

NCT00524290

TERMINATED Phase 1

Active Immunization of Patients With Carcinoma of Oral Cavity or Oropharynx With Autologous Dendritic Cells Transfected With DNA From Autologous Tumor

NCT00377247

COMPLETED

Clinical and Microbiologic Characteristics of Cephalosporin-Resistant E. Coli-PITT Protocol

NCT00877708

COMPLETED NA

Evaluation of Group Lifestyle Balance Maintenance Strategies

NCT00869609

COMPLETED NA

Acupuncture for the Treatment of Insomnia

NCT00855140

COMPLETED

Neurobiological Correlates of Post Traumatic Stress Disorder (PTSD) During Rapid Eye Movement (REM) Sleep

NCT00871650

COMPLETED NA

Sleep, Mood, and Behavior Study

NCT00787397

COMPLETED

African-American Bone Metabolism and Lactation Study

NCT00785824

COMPLETED NA

Comparing Methods for Tracking Health Information at Home After Lung Transplant

NCT00818025

COMPLETED NA

The Effect of Alternative Keyboards on Discomfort and Typing Kinematics

NCT00801983

COMPLETED

Prevalence and Pathogenesis of Lung Disease in a Large HIV Cohort-coordinating Center

NCT00870857

COMPLETED Phase 1

Comparison of Biomarker Modulation by Inhibition of EGFR and/or SRC Family

NCT00779389

COMPLETED

Lung HIV Disease in a Large Cohort-Pitt

NCT01326572

COMPLETED NA

Ultrasound Guided Core Biopsy vs Fine Needle Aspiration for Evaluation of Axillary Lymphadenopathy

NCT01920139

COMPLETED Phase 1

Safety Study Involving Oxaliplatin With Docetaxel for Recurrent Ovarian,Primary Peritoneal, and Fallopian Tube Cancer

NCT00692900

COMPLETED

Assessing the Prognosis of Pulmonary Embolism Using Clinical and Imaging Biomarkers (Retrospective & Prospective )

NCT00805246

COMPLETED NA

Automated Clinical Reminders in the Care of Chronic Kidney Disease Patients

NCT00688285

TERMINATED NA

Randomized Fistula Study

NCT00808561

TERMINATED NA

Human Upper Extremity (Hand and Forearm) Allotransplantation

NCT00722280

COMPLETED Phase 2

LC Drug Eluting Bead for Treatment of Liver Cancer Which Cannot be Surgically Removed

NCT00877071

COMPLETED Phase 2

Radiation, Cetuximab and Pemetrexed With or Without Bevacizumab in Locally Advanced Head and Neck Cancer

NCT00703976

COMPLETED

Study of Genes in Relation to Seasonal Affective Disorder and Major Depressive Disorder

NCT01292889

COMPLETED Phase 3

Sensoril(Ashwaganhda)for Bipolar Disorder

NCT00761761

COMPLETED NA

Electronic Notification of Teratogenic Risks

NCT00766207

COMPLETED Phase 2

Duration of Hypothermia for Neuroprotection After Pediatric Cardiac Arrest

NCT00797680

COMPLETED NA

Transdisciplinary Studies of CBT for Anxiety in Youth: Child Anxiety Treatment Study

NCT00774150

COMPLETED Phase 1

Defining Vitamin D Insufficiency in School Age Children: A Randomized Placebo Controlled Trial of Vitamin D3

NCT00732758

COMPLETED Phase 2

The Effect of Neuromuscular Electrical Stimulation (NMES)

NCT00765739

TERMINATED NA

Effect of Dietary and Life Style Modification on Post Liver Transplant Obesity

NCT00878592

COMPLETED

The North American Pancreatitis Study

NCT01545167

COMPLETED NA

Reducing Medical Risks in Individuals With Bipolar Disorder - Full Study

NCT00746343

TERMINATED Phase 1

Phase I/II Study of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin for Acute Myeloid Leukemia

NCT00660036

COMPLETED

Ventricular Tachyarrhythmia (VT) Storm, Gene Expression in Implantable Cardioverter Defibrillator (ICD) Patients With Electrical Storm

NCT00284453

COMPLETED NA

Pediatric Ethanol Lock Therapy Study.

NCT00948441

COMPLETED Early Phase 1

STAT3 DECOY in Head and Neck Cancer

NCT00696176

TERMINATED Phase 4

Effectiveness of Nimodipine Plus Antidepressant Medication in Treating Vascular Depression

NCT00781326

COMPLETED

A Validation Study of Genzyme Diagnostics OSOM Trichomonas Rapid Test and BVBlue Test

NCT00682851

TERMINATED Phase 4

Tranexamic Acid for Craniofacial Surgery

NCT00722436

TERMINATED NA

Ischemic Foot Ulcers: Is Intervention Better Than Wound Care Alone

NCT00731835

← Previous Page 18 of 25 Next →

Phase Distribution

PhaseTrial count
Phase 1 81
Phase 2 79
Phase 3 28
Phase 4 56

What is open in the University of Pittsburgh pipeline

160 recruiting of 1,238 indexed (13% open); 917 completed (74%).

Phase mix: 84 late (III/IV) vs 160 early (I/II) (early-phase heavy).

Top condition: Depression (17 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Pittsburgh: open-pipeline peers nationwide

Peers matched on 1,238 registered trials and 13% open enrollment, not the therapeutic-area sidebar.

University of Pittsburgh sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 12%14%16%18%20%22% Total trials Recruiting share University of PittsburghNorthwestern UniversityEmory UniversityUniversity of Colorado, DenverAstraZenecaIntermountain Health CareMcMaster UniversityNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Temple University
University of Pittsburgh sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Pittsburgh sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,238 trials (± recruiting share)

Sponsors near 13% open enrollment (± trial volume)

What to do with this University of Pittsburgh page

1,238 registered trials is a research-attention snapshot, not an endorsement of University of Pittsburgh or any single study.

  • 160 of University of Pittsburgh's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Depression is the condition University of Pittsburgh studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Pittsburgh pipeline card: 1,238 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.